Emerging evidence has illustrated that combining the GLP-1Ras with GIP Ras is an integrated potency to achieve significantly weight-losing along with glycemia control effect [11], which may provide a novel therapeutic option for the treatment of T2D [12]. The gene discussed is GIP; the disease is type 2 diabetes mellitus.